{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:27:30Z","timestamp":1791300450436,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03850-x","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:10:16Z","timestamp":1744643416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Machine learning-based disease risk stratification and prediction of metabolic dysfunction-associated fatty liver disease using vibration-controlled transient elastography: Result from NHANES 2021\u20132023"],"prefix":"10.1186","volume":"25","author":[{"given":"Liqiong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"3","key":"3850_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842\u201352.","journal-title":"J Hepatol"},{"issue":"4","key":"3850_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"3850_CR3","doi-asserted-by":"publisher","first-page":"9132","DOI":"10.3390\/cimb45110573","volume":"45","author":"B Filipovic","year":"2023","unstructured":"Filipovic B, Marjanovic-Haljilji M, Mijac D, Lukic S, Kapor S, Kapor S, et al. Molecular Aspects of MAFLD-New Insights on Pathogenesis and Treatment. Curr Issues Mol Biol. 2023;45(11):9132\u201348.","journal-title":"Curr Issues Mol Biol"},{"key":"3850_CR4","doi-asserted-by":"publisher","first-page":"204201882211455","DOI":"10.1177\/20420188221145549","volume":"14","author":"RM Pipitone","year":"2023","unstructured":"Pipitone RM, Ciccioli C, Infantino G, La Mantia C, Parisi S, Tulone A, et al. MAFLD: a multisystem disease. Ther Adv Endocrinol Metab. 2023;14:20420188221145548.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"3850_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","volume":"65","author":"R Kwok","year":"2016","unstructured":"Kwok R, Choi KC, Wong GL, Zhang Y, Chan HL, Luk AO, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut. 2016;65(8):1359\u201368.","journal-title":"Gut"},{"issue":"11","key":"3850_CR6","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","volume":"25","author":"JH Zhou","year":"2019","unstructured":"Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World J Gastroenterol. 2019;25(11):1307\u201326.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3850_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","volume":"75","author":"EA Selvaraj","year":"2021","unstructured":"Selvaraj EA, M\u00f3zes FE, Jayaswal ANA, Zafarmand MH, Vali Y, Lee JA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol. 2021;75(4):770\u201385.","journal-title":"J Hepatol"},{"issue":"1","key":"3850_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, et al. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019;17(1):156-163.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3850_CR9","doi-asserted-by":"publisher","first-page":"848937","DOI":"10.3389\/fendo.2022.848937","volume":"13","author":"C Zhu","year":"2022","unstructured":"Zhu C, Huang D, Ma H, Qian C, You H, Bu L, et al. High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease. Front Endocrinol (Lausanne). 2022;13:848937.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"3850_CR10","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1111\/liv.70042","volume":"45","author":"LA Patmore","year":"2025","unstructured":"Patmore LA, van Eekhout K, Koc \u00d6M, de Knegt RJ, Janssen HLA, Brouwer WP, et al. The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B. Liver Int. 2025;45(3):e70042.","journal-title":"Liver Int"},{"issue":"1","key":"3850_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"10","key":"3850_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3850_CR13","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.2147\/DMSO.S417754","volume":"16","author":"F Zhang","year":"2023","unstructured":"Zhang F, Han Y, Zheng L, Liu J, Wu Y, Bao Z, et al. Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2023;16:2255\u201368.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"3850_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000526373","volume":"78","author":"J Lischka","year":"2022","unstructured":"Lischka J, Lieb K, Schanzer A, Hojreh A, Ba-Ssalamah A, de Gier C, et al. Risk Scores for Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric Obesity. Ann Nutr Metab. 2022;78(5):247\u201354.","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"3850_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5582\/bst.2022.01473","volume":"17","author":"J Xu","year":"2023","unstructured":"Xu J, Liu X, Wu S, Zhang D, Liu X, Xia P, et al. RNA-binding proteins in metabolic-associated fatty liver disease (MAFLD): From mechanism to therapy. Biosci Trends. 2023;17(1):21\u201337.","journal-title":"Biosci Trends"},{"key":"3850_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2147\/DMSO.S407657","volume":"16","author":"D Zhang","year":"2023","unstructured":"Zhang D, Zhang L, Chen S, Chen R, Zhang X, Bai F. Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease Among Hospital Staff. Diabetes Metab Syndr Obes. 2023;16:1221\u201334.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"3850_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5152\/tjg.2021.20498","volume":"32","author":"A Avcu","year":"2021","unstructured":"Avcu A, Kaya E, Yilmaz Y. Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic. Turk J Gastroenterol. 2021;32(5):466\u201372.","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"3850_CR18","doi-asserted-by":"publisher","first-page":"21925","DOI":"10.1038\/s41598-022-25843-6","volume":"12","author":"A Nogami","year":"2022","unstructured":"Nogami A, Yoneda M, Iwaki M, Kobayashi T, Kessoku T, Honda Y, et al. Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD. Sci Rep. 2022;12(1):21925.","journal-title":"Sci Rep"},{"key":"3850_CR19","doi-asserted-by":"publisher","first-page":"1499013","DOI":"10.3389\/fmed.2024.1499013","volume":"11","author":"S Dawod","year":"2024","unstructured":"Dawod S, Brown K. Non-invasive testing in metabolic dysfunction-associated steatotic liver disease. Front Med (Lausanne). 2024;11:1499013.","journal-title":"Front Med (Lausanne)"},{"issue":"15","key":"3850_CR20","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jama.2024.1447","volume":"331","author":"H Lin","year":"2024","unstructured":"Lin H, Lee HW, Yip TC, Tsochatzis E, Petta S, Bugianesi E, et al. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease. JAMA. 2024;331(15):1287\u201397.","journal-title":"JAMA"},{"issue":"6","key":"3850_CR21","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"2","key":"3850_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/dc20-1997","volume":"44","author":"R Lomonaco","year":"2021","unstructured":"Lomonaco R, Godinez Leiva E, Bril F, Shrestha S, Mansour L, Budd J, et al. Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening. Diabetes Care. 2021;44(2):399\u2013406.","journal-title":"Diabetes Care"},{"issue":"1","key":"3850_CR23","doi-asserted-by":"publisher","first-page":"101506","DOI":"10.1016\/j.diabet.2023.101506","volume":"50","author":"J Bilson","year":"2024","unstructured":"Bilson J, Mantovani A, Byrne CD, Targher G. Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes Metab. 2024;50(1):101506.","journal-title":"Diabetes Metab"},{"issue":"23","key":"3850_CR24","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.3390\/nu15234870","volume":"15","author":"J Feehan","year":"2023","unstructured":"Feehan J, Mack A, Tuck C, Tchongue J, Holt DQ, Sievert W, et al. Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease-A Single Blinded Crossover Trial. Nutrients. 2023;15(23):4870.","journal-title":"Nutrients"},{"issue":"1","key":"3850_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","volume":"20","author":"G Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20(1):134.","journal-title":"Lipids Health Dis"},{"key":"3850_CR26","doi-asserted-by":"publisher","first-page":"1094101","DOI":"10.3389\/fendo.2023.1094101","volume":"14","author":"Y Xing","year":"2023","unstructured":"Xing Y, Zhen Y, Yang L, Huo L, Ma H. Association between hemoglobin glycation index and non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2023;14:1094101.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"3850_CR27","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.3390\/nu15102335","volume":"15","author":"A Dolce","year":"2023","unstructured":"Dolce A, Della TS. Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution. Nutrients. 2023;15(10):2335.","journal-title":"Nutrients"},{"issue":"4","key":"3850_CR28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology. 2019;70(4):1457\u201369.","journal-title":"Hepatology"},{"issue":"21","key":"3850_CR29","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.3390\/nu14214556","volume":"14","author":"K Riazi","year":"2022","unstructured":"Riazi K, Swain MG, Congly SE, Kaplan GG, Shaheen AA. Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients. 2022;14(21):4556.","journal-title":"Nutrients."},{"issue":"4","key":"3850_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.dld.2023.11.040","volume":"56","author":"Z Ren","year":"2024","unstructured":"Ren Z, Wesselius A, Stehouwer CDA, Brouwers MCGJ. Relationship between educational attainment and non-alcoholic fatty liver disease: A two-sample Mendelian randomization study. Dig Liver Dis. 2024;56(4):565\u201370.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"3850_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12902-023-01318-1","volume":"23","author":"H Fu","year":"2023","unstructured":"Fu H, Yu H, Zhao Y, Chen J, Liu Z. Association between hypertension and the prevalence of liver steatosis and fibrosis. BMC Endocr Disord. 2023;23(1):85.","journal-title":"BMC Endocr Disord"},{"key":"3850_CR32","doi-asserted-by":"publisher","first-page":"1083032","DOI":"10.3389\/fendo.2023.1083032","volume":"14","author":"H Peng","year":"2023","unstructured":"Peng H, Pan L, Ran S, Wang M, Huang S, Zhao M, et al. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults. Front Endocrinol (Lausanne). 2023;14:1083032.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"3850_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12944-022-01748-1","volume":"21","author":"H Zou","year":"2022","unstructured":"Zou H, Zhao F, Lv X, Ma X, Xie Y. Development and validation of a new nomogram to screen for MAFLD. Lipids Health Dis. 2022;21(1):133.","journal-title":"Lipids Health Dis"},{"key":"3850_CR34","doi-asserted-by":"publisher","first-page":"205520762412725","DOI":"10.1177\/20552076241272535","volume":"10","author":"L Liu","year":"2024","unstructured":"Liu L, Lin J, Liu L, Gao J, Xu G, Yin M, et al. Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017\u20132020. Digit Health. 2024;10:20552076241272536.","journal-title":"Digit Health"},{"key":"3850_CR35","doi-asserted-by":"publisher","first-page":"977625","DOI":"10.3389\/fendo.2022.977625","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Zhang Y, Luo H, Lin R. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Front Endocrinol (Lausanne). 2022;13:977625.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3850_CR36","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1038\/s41598-022-06998-8","volume":"12","author":"V Blanes-Vidal","year":"2022","unstructured":"Blanes-Vidal V, Lindvig KP, Thiele M, Nadimi ES, Krag A. Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care. Sci Rep. 2022;12(1):2914.","journal-title":"Sci Rep"},{"issue":"3","key":"3850_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/jgh.15385","volume":"36","author":"GL Wong","year":"2021","unstructured":"Wong GL, Yuen PC, Ma AJ, Chan AW, Leung HH, Wong VW. Artificial intelligence in prediction of non-alcoholic fatty liver disease and fibrosis. J Gastroenterol Hepatol. 2021;36(3):543\u201350.","journal-title":"J Gastroenterol Hepatol."},{"issue":"1","key":"3850_CR38","doi-asserted-by":"publisher","first-page":"11170","DOI":"10.1038\/s41598-024-62124-w","volume":"14","author":"D Lv","year":"2024","unstructured":"Lv D, Wang Z, Meng C, Li Y, Ji S. A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination. Sci Rep. 2024;14(1):11170.","journal-title":"Sci Rep"},{"issue":"20","key":"3850_CR39","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.3390\/ijms232012481","volume":"23","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Taverna A, Cappelli D, Beatrice G, Csermely A, Sani E, et al. Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. Int J Mol Sci. 2022;23(20):12481.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3850_CR40","doi-asserted-by":"publisher","first-page":"102420","DOI":"10.1016\/j.jceh.2024.102420","volume":"15","author":"X Huang","year":"2025","unstructured":"Huang X, Yu R, Tan X, Guo M, Xia Y, Zou H, et al. Comparison of NAFLD, MAFLD, and MASLD Prevalence and Clinical Characteristics in Asia Adults. J Clin Exp Hepatol. 2025;15(1):102420.","journal-title":"J Clin Exp Hepatol"},{"key":"3850_CR41","doi-asserted-by":"publisher","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13:951689.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3850_CR42","doi-asserted-by":"publisher","first-page":"155294","DOI":"10.1016\/j.metabol.2022.155294","volume":"136","author":"J Ye","year":"2022","unstructured":"Ye J, Zhuang X, Li X, Gong X, Sun Y, Wang W, et al. Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation. Metabolism. 2022;136:155294.","journal-title":"Metabolism"},{"issue":"7","key":"3850_CR43","doi-asserted-by":"publisher","first-page":"990","DOI":"10.4254\/wjh.v16.i7.990","volume":"16","author":"WX Liu","year":"2024","unstructured":"Liu WX, Liu L. Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction. World J Hepatol. 2024;16(7):990\u20134.","journal-title":"World J Hepatol"},{"issue":"2","key":"3850_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14218\/JCTH.2021.00188","volume":"10","author":"M Shen","year":"2022","unstructured":"Shen M, Lee A, Lefkowitch JH, Worman HJ. Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center. J Clin Transl Hepatol. 2022;10(2):197\u2013206.","journal-title":"J Clin Transl Hepatol"},{"issue":"7","key":"3850_CR45","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/hep4.1935","volume":"6","author":"M Noureddin","year":"2022","unstructured":"Noureddin M, Ntanios F, Malhotra D, Hoover K, Emir B, McLeod E, et al. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017\u20132018 transient elastography data and application of machine learning. Hepatol Commun. 2022;6(7):1537\u201348.","journal-title":"Hepatol Commun"},{"issue":"1","key":"3850_CR46","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.1038\/s41598-023-32965-y","volume":"13","author":"M Michel","year":"2023","unstructured":"Michel M, Labenz C, Armandi A, Kaps L, Kremer WM, Galle PR, et al. Metabolic dysfunction-associated fatty liver disease in people living with HIV. Sci Rep. 2023;13(1):9158.","journal-title":"Sci Rep"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03850-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T16:02:20Z","timestamp":1744646540000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03850-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3850"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03850-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES program received ethical approval from the NCHS Research Ethics Review Board, and all participants provided written informed consent. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}